Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Hashimoto, Naoko ^a   Maeshima, Yohei ^a   Satoh, Minoru ^a   Odawara, Masahiro ^a   Sugiyama, Hitoshi ^a   Kashihara, Naoki ^b   Matsubara, Hiroaki ^c   Yamasaki, Yasushi ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II receptor; Nitric oxide; Transgenic mouse

Indexed keywords

ALBUMIN; ALPHA ACTIN; ANGIOTENSIN 2 RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULAR INJURY; GLOMERULOPATHY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; URINARY EXCRETION;

EID: 1242351761     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00294.2003     Document Type: Article

References (55)

1. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Cabili S, Silverberg D, and Iaina A. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 47: 1515-1521, 1995.
2. 1. Nature 346: 371-374, 1990.
3. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, De Gasparo M, and Cooper ME. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 13: 1773-1787, 2002.
4. Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, and Rupprecht HD. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int 63: 1302-1312, 2003.
5. Chiu JJ, Wung BS, Hsieh HJ, Lo LW, and Wang DL. Nitric oxide regulates shear stress-induced early growth response-1. Expression via the extracellular signal-regulated kinase pathway in endothelial cells. Circ Res 85: 238-246, 1999.
6. Christy B and Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci USA 86: 8737-8741, 1989.
7. Deguchi J, Makuuchi M, Nakaoka T, Collins T, and Takuwa Y. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms. Circ Res 85: 565-574, 1999.
8. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, and Johnson RJ. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41: 297-309, 1992.
9. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, and Couser WG. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991.
10. Gabizon D, Goren E, Shaked U, Averbukh Z, Rosenmann E, and Modai D. Induction of chronic renal failure in the mouse: a new model. Nephron 40: 349-352, 1985.
11. Gagnon RF and Ansari M. Development and progression of uremic changes in the mouse with surgically induced renal failure. Nephron 54: 70-76, 1990.
12. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, Blum R, Herman T, Abraham PA, Halstenson CN, Lo M, Lu H, and Spector R. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension 25: 37-46, 1995.
13. Goodfriend TL, Elliott ME, and Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 334: 1649-1654, 1996.
14. Gross SS and Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57: 737-769, 1995.
15. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, and Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103: 627-635, 1999.
16. Hofer G, Grimmer C, Sukhatme VP, Sterzel RB, and Rupprecht HD. Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem 271: 28306-28310, 1996.
17. Huang XC, Richards EM, and Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem 271: 15635-15641, 1996.
18. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, and Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597-2601, 1993.
19. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, and Alpers CE. The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 2: S190-S197, 1992.
20. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, and Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416, 1992.
21. 1 in the rat remnant kidney. J Am Soc Nephrol 8: 1732-1738, 1997.
22. Khachigian LM, Williams AJ, and Collins T. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem 270: 27679-27686, 1995.
23. Kone BC and Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol Renal Physiol 272: F561-F578, 1997.
24. Kren S and Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 56: 333-337, 1999.
25. Kroncke KD, Fehsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, Bettermann H, Breunig KD, and Kolb-Bachofen V. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 200: 1105-1110, 1994.
26. Lafayette RA, Mayer G, Park SK, and Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992.
27. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, and Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53: 937-944, 1998.
28. Mackman N. Regulation of the tissue factor gene. FASEB J 9: 883-889, 1995.
29. Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, Kanao K, Watanabe Y, Kanwar YS, and Makino H. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest 101: 2589-2597, 1998.
30. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, and Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 276: 15240-15248, 2001.
31. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, and Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295: 140-143, 2002.
32. 1 receptor-mediated pressor and chronotropic effects. J Clin Invest 101: 527-535, 1998.
33. Matsubara H and Inada M. Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. Endocr J 45: 137-150, 1998.
34. 2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization. Nephron 80: 25-34, 1998.
35. 2 angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci USA 88: 11440-11444, 1991.
36. Moskowitz DW and Liu W. Gene expression after uninephrectomy in the rat: simultaneous expression of positive and negative growth control elements. J Urol 154: 1560-1565, 1995.
37. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
38. Ouellette AJ, Malt RA, Sukhatme VP, and Bonventre JV. Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 85: 766-771, 1990.
39. 2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
40. Plum J, Bunten B, Nemeth R, and Grabensee B. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. J Am Soc Nephrol 9: 2223-2234, 1998.
41. Roczniak A, Fryer JN, Levine DZ, and Burns KD. Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J Am Soc Nephrol 10: 704-713, 1999.
42. Rupprecht HD, Akagi Y, Keil A, and Hofer G. Nitric oxide inhibits growth of glomerular mesangial cells: role of the transcription factor EGR-1. Kidney Int 57: 70-82, 2000.
43. Rupprecht HD, Hoffer G, de Heer E, Sterzel RB, Faller G, and Schoecklmann HO. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation. Kidney Int 51: 694-702, 1997.
44. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, and Makino H. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001.
45. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, and Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol Renal Fluid Electrolyte Physiol 262: F236-F240, 1992.
46. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
47. Siragy HM, Howell NL, Ragsdale NV, and Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25: 1021-1024, 1995.
48. 2) angiotensin receptor. Proc Natl Acad Sci USA 96: 6506-6510, 1999.
49. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657, 1995.
50. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, and Murakami K. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722, 1995.
51. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, and Ota A. Apoptosis in glomerular sclerosis. Kidney Int 49: 103-111, 1996.
52. Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, and Tsai-Morris CH. A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1: 343-355, 1987.
53. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, and Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104: 925-935, 1999.
54. 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 51: 1553-1567, 1997.
55. Zhang H, Wada J, Kanwar YS, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, and Makino H. Screening for genes up-regulated in 5/6 nephrectomized mouse kidney. Kidney Int 56: 549-558, 1999.